title: R&D productivity: on the comeback trail.
authors.affiliation: The Boston Consulting Group, Münstergasse 2, 8001 Zürich, Switzerland.
authors.forename: Ulrik
authors.initials: U
authors.lastname: Schulze
authors.affiliation: The Boston Consulting Group, Ludwigstraße 21, 80539 München, Germany.
authors.forename: Mathias
authors.initials: M
authors.lastname: Baedeker
authors.affiliation: The Boston Consulting Group, The New Otani Garden Court, 4-1, Kioi-cho, Chiyoda-ku, Tokyo 102-0094, Japan.
authors.forename: Yen Ting
authors.initials: YT
authors.lastname: Chen
authors.affiliation: The Boston Consulting Group, Münstergasse 2, 8001 Zürich, Switzerland.
authors.forename: David
authors.initials: D
authors.lastname: Greber
mesh_terms: D000818:Animals; D017277:Drug Approval / Q000191:economics; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D004526:Efficiency; D006801:Humans; D012106:Research / Q000191:economics / Q000639:trends*
references.citation: Nat Rev Drug Discov. 2011 Aug 31;10(9):653-4
references.pmid: 21878973
references.citation: Nat Rev Drug Discov. 2013 Dec;12(12):901-2
references.pmid: 24136396